Abstract
Women with lobular carcinoma in situ (LCIS), atypical lobular hyperplasia (ALH), atypical ductal hyperplasia (ADH), or atypical hyperplasia (AH) are at increased breast cancer (BC) risk. We investigated the accuracy and outcomes of mammography screening in women with histology-proven LCIS, ALH, ADH, or AH history who had screening through Breast Cancer Surveillance Consortium-affiliated mammography facilities. Screens from two cohorts, defined by LCIS/ALH or ADH/AH history, were compared to two cohorts without such history mammogram-matched for age-group, breast density, family history, screen-year, and mammography registry. Overall 359 BCs (277 invasive BC) occurred within 1 year from screening among 52,380 screens. In the LCIS/ALH cohort [versus comparator screens] cancer incidence rates, cancer detection rates (CDR), and interval cancer rates (ICR) were significantly higher (all P < 0.001); although ICR was 4.4/1,000 screens [versus 0.9/1,000; P < 0.001] the proportion that were interval cancers did not differ between compared cohorts (P = 0.43); screening sensitivity was 76.1 % [versus 82.3 %; P = 0.43], however, specificity was significantly lower at 85.1 % [versus 90.7 %; P < 0.0001]. In the ADH/AH cohort [versus comparator] cancer rates and CDR were significantly higher (P < 0.001); although ICR was 2.6/1,000 screens [versus 0.9/1,000; P = 0.002] the proportion that were interval cancers did not differ between cohorts (P = 0.74); screening sensitivity was 81.0 % [versus 82.6 %; P = 0.74] and specificity was lower at 86.2 % [versus 90.2 %; P < 0.0001]. Mammography screening sensitivity in LCIS/ALH and ADH/AH cohorts did not significantly differ from that of matched screens, however, specificity was lower, and ICRs were higher (reflecting underlying cancer rates). Adjunct screening may be of value in these women if it reduces ICR without substantially reducing specificity.
Similar content being viewed by others
References
Saslow D, Boetes C, Burke W et al (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57(2):75–89
Lord SJ, Lei W, Craft P et al (2007) A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer 43(13):1905–1917
Lakhani SR, Audretsch W, Cleton-Jensen AM et al (2006) The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)? Eur J Cancer 42(14):2205–2211
Tice JA, O’Meara ES, Weaver DL, Vachon C, Ballard-Barbash R, Kerlikowske K (2013) Benign breast disease, mammographic breast density, and the risk of breast cancer. J Natl Cancer Inst 105(14):1043–1049
Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ (2007) Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses’ Health Study. Cancer 109(2):180–187
Page DL, Schuyler PA, Dupont WD, Jensen RA, Plummer WD Jr, Simpson JF (2003) Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study.[Erratum appears in Lancet. 2003 Jun 7; 361(9373):1994]. Lancet 361(9352):125–129
Page DL, Kidd TE Jr, Dupont WD, Simpson JF, Rogers LW (1991) Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 22(12):1232–1239
Dupont WD, Page DL (1985) Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312(3):146–151
Dupont WD, Page DL (1989) Relative risk of breast cancer varies with time since diagnosis of atypical hyperplasia. Hum Pathol 20(8):723–725
Sung JS, Malak SF, Bajaj P, Alis R, Dershaw DD, Morris EA (2011) Screening breast MR imaging in women with a history of lobular carcinoma in situ. Radiology 261(2):414–420
Friedlander LC, Roth SO, Gavenonis SC (2011) Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ. Radiology 261(2):421–427
Port ER, Park A, Borgen PI, Morris E, Montgomery LL (2007) Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia. Ann Surg Oncol 14(3):1051–1057
Ballard-Barbash R, Taplin SH, Yankaskas BC et al (1997) Breast cancer surveillance consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol 169(4):1001–1008
Houssami N, Ciatto S, Ellis I, Ambrogetti D (2007) Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specific estimates. Cancer 109(3):487–495
Yankaskas BC, Taplin SH, Ichikawa L et al (2005) Association between mammography timing and measures of screening performance in the United States. Radiology 234(2):363–373
Rosenberg RD, Yankaskas BC, Abraham LA et al (2006) Performance benchmarks for screening mammography. Radiology 241(1):55–66
American College of Radiology (ACR) (2003) Breast imaging reporting and data system (BI-RADS), 4th edn. American College of Radiology, Reston
Visvanathan K, Hurley P, Bantug E et al (2013) Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 31(23):2942–2962
King TA, Muhsen S, Patil S et al (2013) Is there a role for routine screening MRI in women with LCIS? Breast Cancer Res Treat 142(2):445–453
Taplin SH, Abraham L, Geller BM et al (2010) Effect of previous benign breast biopsy on the interpretive performance of subsequent screening mammography. J Natl Cancer Inst 102(14):1040–1051
Acknowledgments
Data and analytic support were provided by the National Cancer Institute-funded BCSC (HHSN261201100031C, P01CA154292). Collection of cancer data was supported by several state public health departments and cancer registries throughout the US. These sources are described at: http://www.breastscreening.cancer.gov/work/acknowledgement.html. We thank the participating women, mammography facilities, and radiologists for data provided for this study. A list of the BCSC investigators and procedures for requesting data for research are available at: http://breastscreening.cancer.gov/. N. Houssami receives research support from the National Breast Cancer Foundation (NBCF Australia).
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Houssami, N., Abraham, L.A., Onega, T. et al. Accuracy of screening mammography in women with a history of lobular carcinoma in situ or atypical hyperplasia of the breast. Breast Cancer Res Treat 145, 765–773 (2014). https://doi.org/10.1007/s10549-014-2965-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-014-2965-z